The Hamps Bio IPO has been structured as a fixed price issue amounting to Rs 6.22 crores. A total of 12.2 lakh shares are being issued entirely as a fresh offering.
The subscription period for the Hamps Bio IPO has been scheduled to open on December 13, 2024, and to close on December 17, 2024. The allotment of shares is expected to be finalized by Wednesday, December 18, 2024. Listing on the BSE SME has been tentatively planned for Friday, December 20, 2024.
The price of the IPO has been fixed at ₹51 per share. A minimum application size of 2000 shares has been specified. Retail investors are required to make a minimum investment of ₹102,000, while HNIs are required to invest in a minimum of 2 lots (4,000 shares), amounting to ₹204,000.
Get the Hamps Bio IPO RHP for detailed information.
| IPO Date | December 13, 2024 to December 14, 2024 |
| Listing Date | -- |
| Face Value | ₹ 10 / Share |
| Price Band | ₹ 51 to ₹ -- / Share |
| Lot Size | 2000 Shares |
| Total Issue Size | ₹6.22 Cr |
| Fresh Issue | ₹6.22 Cr |
| Offer for Sale | |
| Employee Discount | |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Share holding pre issue | 3,136,000 |
| Share holding post issue | 4,356,000 |
| Market Maker portion | 62,000 shares |
Hamps Bio Limited IPO opens on December 13, 2024, and closes on December 14, 2024.
| IPO Open Date | December 13, 2024 |
| IPO Close Date | December 14, 2024 |
| Basis of Allotment | December 18, 2024 |
| Initiation of Refunds | December 19, 2024 |
| Credit of Shares to Demat | December 19, 2024 |
| Listing Date | -- |
| Cut-off time for UPI mandate confirmation | December 17, 2024 |
A minimum bid of 2000 shares and multiples thereof is permitted. The table below illustrates the minimum and maximum investment requirements for retail investors and HNIs, represented in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | |
| Retail (Max) | 1 | 2,000 | |
| S-HNI (Min) | 2 | 4,000 | |
| S-HNI (Max) | |||
| B-HNI (Min) | |||
| HNI (Min) |
| Share Holding Pre Issue | 100.00% |
| Share Holding Post Issue | 71.99% |
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | |
|
| Market Maker Shares Offered | |
|
| Other Shares Offered | |
|
| QIB Shares Offered | |
|
| NII (HNI) Shares Offered | |
|
| bNII > ₹10L | |
|
| sNII < ₹10L | |
|
| Retail Shares Offered | |
|
| Employee Shares Offered | |
|
| Total Shares Offered | |
| Bid Date | |
| Shares Offered | |
| Anchor Portion Size (In Cr.) | |
| Anchor lock-in period end date for 50% shares (30 Days) | |
| Anchor lock-in period end date for remaining shares (90 Days) |
Incorporated in 2007, Hamps Bio Limited is involved in the marketing and distribution of pharmaceutical products, including tablets, syrups, capsules, injectables, oils, and nutritional supplements.
The distribution of its products is carried out through a network of over 50 distributors and various e-commerce platforms such as Amazon (US, Canada, EU), Flipkart, and Jio Mart. The company's pharmaceutical products are made available across 8 states and union territories, while freeze-dried and frozen products are distributed to 6 countries and 22 states and union territories.
| KPI | Values |
|---|---|
| ROE | 21.14% |
| ROCE | 18.31% |
| Debt/Equity | 0.31 |
| RoNW | 14.84% |
| P/BV | 2.96 |
| PAT Margin (%) | 7.73 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 1.6 | 1.34 |
| P/E (x) | 31.94 | 38.03 |
The proceeds are planned to be utilized for the following purposes:
Hamps Bio Limited 2900/112, GIDC, Near Atul Limited, Ankleshwar, Bharuch 393 002 Phone: +91 8000006663 Email: info@hampsbio.com Website: http://www.hampsbio.com/ |
Bigshare Services Pvt. Ltd Phone: +91-22-6263 8200 Email: ipo@bigshareonline.com Website: https://ipo.bigshareonline.com/ipo_status.html |
Lamfindia specializes in offering innovative financial solutions, including stock broker services, mutual fund investments, and IPO guidance.